Metformin was also studied regarding COPD exacerbations in patients without T2D, but failed to demonstrate any improvement in blood glucose control, nor effects on CRP or clinical outcomes in the non-diabetic population [187]. The gene discussed is CRP; the disease is type 2 diabetes mellitus.